Cutaneous Lymphoma Catalyst Grant

Catalyst

The Cutaneous Lymphoma Foundation (CLF), with support from the Leukemia & Lymphoma Society (LLS), announced the inaugural year of the Cutaneous Lymphoma Catalyst Research Grant, a new funding initiative exclusively for cutaneous lymphoma research, in August 2019.

The CLF’s mission is to support every person with cutaneous lymphoma by promoting awareness and education, advancing patient care, and facilitating research.

To help achieve this mission, the Foundation’s new Research Awards Program (RAP) is designed to help further efforts of researchers conducting innovative cutaneous lymphoma research while they investigate the causes and improve treatments, and clinical care and quality of life for patients. Discovering new avenues for better therapies and, one day, a cure for cutaneous lymphoma are key aims of this program.